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11 VALORIZATION ADDENDUM 
Brachytherapy has been under continuous development for more than a century now, 
improved outcomes result from increased accuracy in radiation delivery. Currently, the 
conventional water based dose formalism, TG-43U1, is being replaced with more accurate 
models. However, important technical challenges need to be overcome before a definitive 
clinical implementation of the recently developed technologies can be realised.  Some of 
these aspects were evaluated in this thesis, aiming to provide knowledge and resources to 
move towards more accurate treatment plans and radiation dose delivery.  
This study was performed in two countries, Brazil and the Netherlands, in 
collaboration with hospitals from Sweden and Belgium. It demonstrates an international 
interest in brachytherapy and the potential application of the acquired knowledge.  
 
11.1 Innovation 
 This thesis aims to improve brachytherapy treatment and can be divided into four 
specific novel subjects.  
 
11.1.1 Model Based Dose Calculation Algorithm  
 AMIGOBrachy (A Medical Image-based Graphical platfOrm - Brachytherapy 
module) is software developed to create an efficient and powerful user-friendly graphical 
interface, needed to integrate clinical treatment plans with MC simulations. It does this by 
providing the main resources required to process and edit images, import and edit treatment 
plans, as well as set MC simulation parameters. It is the first software to provide all these 
functionalities combined with the capability to import and verify treatment plans created with 
commercial TPS (Treatment Planning System) through MC calculations. In addition, 
AMIGOBrachy can account for source movement, calculate different dose reporting 
quantities, mean energy and photon energy spectrum. All of these features are not currently 
available in typical clinical practice.   
 
11.1.2 CAD-Mesh geometries 
The modelling of complex brachytherapy applicators can be suboptimal when using 
voxel based geometry, due to the sub-voxel dimensions of specific components.  In addition, 
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applicator modelling using constructive solid geometry can be tedious, and may not allow 
complete fidelity or may be highly impractical, as is the case for deformable balloon 
applicators employed in accelerated partial breast irradiation (APBI).  
Some modelling limitations can be avoided with CAD-Mesh geometries that can be 
imported by recent versions of general purpose MC codes. This thesis is the first study to 
evaluate CAD-Mesh models of brachytherapy applicators through MC simulations. 
Moreover, it is the most accurate method to model deformable applicators (APBI balloon 
applicator – item 4.3) available thus far.  
 
11.1.3 Dose specification  
Dose reporting quantities are especially relevant since the transition from the TG-
43U1 formalism to more accurate dose calculation algorithms will make both Dm,m and Dw,m  
quantities available in typical clinical practice very soon.  Differences between dose reporting 
in terms of Dm,m and Dw,m have been discussed in the literature with arguments in favor and 
against both quantities. However, this is the first study to show how differences in the photon 
energy spectrum inside of the patient can affect the relation between Dm,m and Dw,m  for 
different tissues. This study can substantially contribute to future judgements regarding which 
quantity should be adopted as the standard in clinical practice.  
 
11.1.4 Transit dose 
The dose component due to source movement inside of the patient is, surprisingly, not 
well known. It is dependent upon the source speed profile which is not well established, with 
reported differences of up to a factor 10 (depending on the measurement methodology). Such 
large differences in the speed values lead to either negligible or highly significant transit 
doses, which was assessed for clinical cases for the first time in this thesis.  These results 
indicate the importance to perform more accurate source speed profile measurements, which 
were conducted in this study for one afterloader model. Speed profiles were obtained using a 
high speed video camera capable of recording up to 960 fps leading to the most accurate 
source speed values available to date.   
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11.2 Clinical relevance  
Patient safety is a priority for medical treatments with hospitals and research centers 
working exhaustively to improve the actual treatment conditions. However, brachytherapy is 
particularly prone to treatment errors, due to the lack of integrated imaging in the treatment 
room, coupled with the high dose gradients employed in the vicinity of radiosensitive healthy 
tissues and due to simplified dose calculation models. Furthermore, treatment plans obtained 
from commercial TPS are not commonly verified using alternative methods such as Monte 
Carlo. There is both a significant risk to underdose the tumor, and to overdose the healthy 
tissues.  
The software developed, AMIGOBrachy (items 4.2  and 5.1),  has a user friendly 
interface that can be readily adopted in clinical practice as an auxiliary dose calculation 
engine. It would provide an independent validation method with the possibility to account for 
applicators, tissues composition and densities. The clinical cases evaluated with 
AMIGOBrachy/MCNP6 show under and overdosing compared to TG-43U1 (item 4.2.4). The 
results obtained prompted  the replacement of hollow cylindrical applicators at one hospital, 
due to a 5% target overdose concern in gynaecological cases.  It was the first direct clinical 
application of this thesis and illustrates how treatment accuracy can be improved, sometimes, 
by adopting simple measures. 
Finally, we provide a novel method to simulate deformable brachytherapy applicators 
(APBI balloon applicator – item 4.3) that cannot be modelled with conventional analytical 
geometry. The CAD-Mesh feature is also an alternative to model rigid brachytherapy 
applicators and may be a suitable option when the applicator model is provided by the 
manufacturer. Although the effect of the applicator can be significant (item 5.2), it is 
currently not taken into account by TPS based on the TG-43U1 formalism.   
 
11.3 Societal relevance 
The scientific findings discussed in this thesis can significantly improve dose 
calculation accuracy and provide relevant information that can be related to RBE effects and 
patient outcome. Therefore, in the short term, treatment plans can be more accurate by 
accounting for applicators, tissue composition, densities and other treatment complexities. In 
the longer term, different dose reporting quantities and mean energy or the energy spectrum 
can be assessed and related to patient outcomes once more data on these quantities becomes 
available.  
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Brachytherapy is widely employed worldwide due to good outcomes. However, the 
technology currently available can move the current standards towards even better outcomes. 
If translated into clinical practice, the developments achieved in this thesis would provide a 
significant contribution to this process.  
Significant efforts were made to incorporate scientific advances into AMIGOBrachy 
so that they are available to the radiotherapy community. The study of different dose 
reporting quantities is an example of such an effort. Additionally, a physical discussion with 
quantitative values for dose reporting quantities were provided for a clinical case, the 
capability to score these quantities are part of AMIGOBrachy and can be used for any clinical 
case.  
  
11.4 Commercial relevance 
AMIGOBrachy may become part of a commercial product in the near future which 
would lead to revenue in the form of royalties, professional support service and training 
courses.  
 
